Detecting gene expression in buccal mucosa in subjects with asthma versus subjects without asthma
Background Differences in mRNA expression for inflammatory markers have been observed between subjects with asthma vs. controls and in relation to corticosteroid response. However, these studies utilized methods (e.g., bronchoscopy) that are too invasive to be used routinely in children and in the c...
Saved in:
Published in | Pediatric allergy and immunology Vol. 24; no. 2; pp. 138 - 143 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
England
Blackwell Publishing Ltd
01.03.2013
Wiley Subscription Services, Inc |
Subjects | |
Online Access | Get full text |
ISSN | 0905-6157 1399-3038 1399-3038 |
DOI | 10.1111/pai.12042 |
Cover
Summary: | Background
Differences in mRNA expression for inflammatory markers have been observed between subjects with asthma vs. controls and in relation to corticosteroid response. However, these studies utilized methods (e.g., bronchoscopy) that are too invasive to be used routinely in children and in the clinic. The primary purpose of this study was to determine the feasibility of obtaining RNA of adequate quantity and quality from buccal mucosa of children and adults for gene expression studies. Secondly, this study aimed to determine whether gene expression patterns in buccal mucosa are similar to those that have been observed in respiratory epithelium.
Methods
We enrolled 94 subjects with and without asthma between 5 and 54 years of age. Relative gene expression in buccal mucosa was determined with quantitative RT‐PCR for the following genes: CCL2, EDN1, FKBP5, IL8, IFNAR2, NFKB1, RELA, SERPINB2, DENND1B, HRH1, ICAM1, ORMDL3, NR3C1, CLCA1, CRHR1, MUC5B, FCER2, POSTN, GAPDH, PPIA.
Results
mRNA Expression of the following genes was detected in buccal mucosa: CCL2, EDN1, FKBP5, IL8, IFNAR2, NFKB1, RELA, SERPINB2, DENND1B, HRH1, ICAM1, ORMDL3, NR3C1, GAPDH, PPIA. HRH1 was differentially expressed in adults with asthma vs. controls (p = 0.04), and EDN1 was differentially expressed in children with asthma vs. controls 12–18 years old (p = 0.03). A similar trend for HRH1 was observed in children 12–18 years old.
Conclusions
Buccal mucosa sampling is a reliable method for detecting changes in gene expression in patients with asthma. This non‐invasive technique may serve as a valuable tool for diagnosing asthma and evaluating therapeutic response. |
---|---|
Bibliography: | ark:/67375/WNG-3W2GD0GV-T Table S1. Gene Expression Assays. Figure S1. Significant correlation between two separate RT-PCR assays for GAPDH mRNA suggest that changes in gene expression can be reproducibly detected in buccal mucosa. Figure S2. Significant correlation between two separate RT-PCR assays for GAPDH mRNA suggest that changes in gene expression can be reproducibly detected in buccal mucosa. Figure S3. Expression of GAPDH mRNA in buccal mucosa is lower in patients with asthma relative to subjects without asthma. istex:D6BDCB84B1F29BD9DDA82E1CC73B50D12E77C8AA ArticleID:PAI12042 ObjectType-Article-1 SourceType-Scholarly Journals-1 content type line 14 ObjectType-Article-2 ObjectType-Undefined-1 ObjectType-Feature-3 content type line 23 ObjectType-Feature-1 |
ISSN: | 0905-6157 1399-3038 1399-3038 |
DOI: | 10.1111/pai.12042 |